US Trade Rep notes pharmaceutical supply chin fragile, Liberation Day tariffs intended to boost safer domestic manufacture

Pennsylvania Congressman Brian Fitzpatrick and US Trade Representative Jamieson Greer discuss concerns about medicines, questioning what work could be done with closest partners and American companies operating in the European Union to ensure that the cost of distinct innovative prescription drugs and medical devices remained affordable for the nation's seniors, particularly those with rare diseases or disabilities, receiving the response that a more secure, resilient, and local supply chain would help with efficiency rather than depending on a fragile global supply chain moving inputs between multiple countries, which might work with just-in-time manufacturing but failed in a world facing conflicts, pandemics, and wars at an annual hearing by the House Ways and Means Committee on the Trump Administration's trade agenda.